tiprankstipranks
Trending News
More News >
Hangzhou Tigermed Consulting Co., Ltd. Class H (HK:3347)
:3347

Hangzhou Tigermed Consulting Co., Ltd. Class H (3347) Similar Stocks

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Hangzhou Tigermed Consulting Co., Ltd. Class H
HK$27.05
€34.62B
51.98
-13.99%
3 Buy
0 Hold
1 Sell
Moderate Buy
Shanghai Fosun Pharmaceutical (Group) Co
HK$14.10
$61.15B
12.34
24.61%
0 Buy
1 Hold
0 Sell
Hold
Livzon Pharmaceutical Group
HK$26.10
$30.23B
10.79
8.52%
0 Buy
0 Hold
0 Sell
Moderate Sell

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:3347
Hangzhou Tigermed Consulting Co., Ltd. Class H
26.00
-4.23
-13.99%
HK:2196
Shanghai Fosun Pharmaceutical (Group) Co
14.10
2.98
26.81%
HK:1513
Livzon Pharmaceutical Group
26.20
2.06
8.52%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis